This post is from a suggested group
Microglobulin Test Kit
The Microglobulin test kit, specifically for Beta-2 Microglobulin (B2M), is a diagnostic tool used to measure a protein found on the surface of almost all cells in the body. B2M is shed into the blood and is typically present in small amounts. However, levels can rise significantly in conditions involving high cell turnover or immune system activation. Consequently, the test kit serves as a vital prognostic indicator in several clinical scenarios.
In oncology, B2M levels are often used to monitor the progression of certain blood cancers, such as multiple myeloma, lymphoma, and leukemia. While the test is not used to diagnose cancer on its own, it provides critical information about the severity of the disease and the patient's likely outcome. Higher levels often correlate with a larger tumor burden and a more aggressive disease course. Clinicians use the results from these kits to tailor treatment plans and evaluate how well…